MADISON DIVIDEND VALUE ETF (DIVL) News

Day 3 of the 2026 National Reimbursement Drug List (NRDL) negotiations: Intensive talks on new "-tinib" drugs as star companies such as BeiGene and Kelun Biotech take the stage.

① In the morning session, a flurry of negotiations centered on "-tin"–class new drugs, with innovative pharmaceutical companies such as Noah Health, Shouyao Holdings, and Jiangsu Weikaiel taking the

cls.cn16:20

These S&P 500 Utilities Stocks Trade Below Their 200-day Average

Seeking Alpha12:57

Day 2 of the 2026 National Reimbursement Drug List (NRDL) negotiations: Two CAR-T therapies vie for basic medical insurance coverage as executives from multiple companies maintain on-site presence.

1. As the national reimbursement drug negotiations entered their second day, several innovative drugs and products with high clinical value were brought to the negotiating table; 2. In line with past practice, innovative drugs that are relatively more difficult to negotiate, such as anti-cancer medications and treatments for rare diseases, tend to be scheduled more intensively in the subsequent days. The lineup of participating companies suggests that this arrangement has largely been maintained.

cls.cn07:53

US and Iran exchange attacks on oil tankers! Iran warns of new "restricted zone" in the Strait of Hormuz, vowing faster, heavier, and more painful retaliation

Renewed hostilities between the United States and Iran have erupted around the Strait of Hormuz, with oil tankers and unmanned systems coming under successive attacks. Iran has threatened to establish new restricted zones and warned that its retaliation would be "faster, heavier, and more painful," even as it grapples with obstructed oil exports and economic distress.

Golden10 Data07:47

Trending Stocks This Week as Markets Weigh Jobs Data and Rates

Seeking Alpha00:13

On-the-ground report from Day 2 of the 2026 NRDL negotiations: Blockbuster oncology drugs, including CAR-T therapies and the world’s first bispecific antibody-drug conjugate (ADC), made their debut, while products covered by commercial insurance sought to

① On the second day of national reimbursement negotiations, the focus shifted to innovative oncology drugs, with nearly 20 companies—including Hengrui Medicine, Eli Lilly and Co, Novartis, and Innovent Biologics—participating in the morning session; ② In the afternoon, multinational pharmaceutical firms took center stage, with Merck & Co, Roche, and Johnson & Johnson successively entering negotiations as several blockbuster innovative drugs were brought to the table; ③ Companies such as Heyuan Biopharma and JW Therapeutics, which emerged as new entrants in commercial health insurance formularies last year, are once again attempting to break into the basic medical insurance scheme, marking the transition of dual-formulary alignment into the practical implementation phase.

cls.cnSep 6 15:29

U.S. military strikes three Iranian oil tankers for the first time, escalating Strait of Hormuz tensions from "targeting infrastructure" to "disrupting transport"

The nature of the military conflict between the United States and Iran underwent a significant shift this week. As U.S. military strikes targeted crude oil tankers in transit for the first time, moving beyond coastal military facilities, this marks a formal escalation from "targeting production capacity and infrastructure" to "disrupting transportation corridors." Consequently, market focus has shifted from "the extent of Iran's production cuts" to "whether the U.S. military intends to systematically sever Iran's crude oil supply chains," prompting a reassessment of global crude oil pricing logic.

wallstreetcnSep 6 15:29

US and Iran exchange attacks on oil tankers! US military claims to have "destroyed" three Iranian oil tankers, while Iran's Islamic Revolutionary Guard Corps reports attacks on multiple oil tankers and US vessels.

US and Iran exchange attacks on oil tankers.

Securities TimesSep 6 09:50

Energy Sector Outperforms in August as Middle East Tensions Boost Oil Prices

Seeking AlphaSep 6 01:05

Insider Trades: Nvidia, TSMC, and Johnson & Johnson Among Notable Names

Seeking AlphaSep 5 23:03

Musk Warns of AI Power Shortfall! Global Surge in Grid Construction Sparks Investment Opportunities in Computing-Power Synergy

The rapid development of AI is driving unprecedented electricity demand, making the urgent expansion and upgrading of global power grids imperative.

cls.cnSep 5 13:33

Bessent: Oil prices to fall to $40 after Iran conflict ends, with bond yields declining accordingly

U.S. Treasury Secretary Bessent predicts that the global oil market will face a severe oversupply once the conflict in Iran ends, potentially driving oil prices down to $40–$50 per barrel and leading to a concurrent decline in bond yields and inflation. He noted that the correlation between current oil prices and interest rates has reached a record high.

wallstreetcnSep 5 05:58

$1000 Invested In Union Pacific 20 Years Ago Would Be Worth This Much Today

Union Pacific (NYSE:UNP) has outperformed the market over the past 20 years by 4.93% on an annualized basis producing an average annual return of 14.16%. Currently, Union Pacific has a market

BenzingaSep 5 05:45

Citadel Sets Sights on U.S. Shale Oil Assets! Previously Bid for WildFire, Ultimately Outmaneuvered by $4 Billion Deal

Citadel is targeting U.S. shale oil assets and has recently engaged with multiple private equity firms to pursue acquisitions. It had previously bid for WildFire Energy, but the asset was ultimately acquired by Magnolia Oil & Gas for approximately $4.06 billion. This reflects an accelerating trend among hedge funds and commodity traders to build positions in physical energy assets, leveraging production capacity to hedge against oil price volatility and geopolitical risks, while further expanding their physical asset exposure within commodity trading operations.

wallstreetcnSep 5 02:05

Industrial Stocks Face Broader Weakness as Bear-market Breadth Hits 2025 High

Seeking AlphaSep 4 22:09

Trump’s inner circle scrambles to enter the market, carving up Venezuela’s oil “big cake”

With the collapse of the Maduro regime and U.S. intervention, Venezuela’s energy sector is experiencing an unprecedented “gold rush,” as business elites with close ties to the Trump administration rapidly move in to stake their claims.

Golden10 DataSep 4 15:27

Polymarket's International Rollout of Perpetual Futures Includes Oil

Seeking AlphaSep 4 04:41

AbbVie Touts Positive Data For Multiple Myeloma Drug

AbbVie Inc. (NYSE:ABBV) on Thursday reported topline outcomes from its Phase 3 CERVINO trial evaluating etentamig, an investigational treatment for relapsed or refractory multiple myeloma.The study

BenzingaSep 4 02:10

BMO Capital Maintains Outperform on Chevron, Raises Price Target to $235

BMO Capital analyst Phillip Jungwirth maintains Chevron (NYSE:CVX) with a Outperform and raises the price target from $210 to $235.

BenzingaSep 4 02:03

TD Cowen Reiterates Buy on CME Group, Maintains $292 Price Target

TD Cowen analyst Bill Katz reiterates CME Group (NASDAQ:CME) with a Buy and maintains $292 price target.

BenzingaSep 3 23:32